The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis

Various chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mecha...

Full description

Bibliographic Details
Main Authors: Gwanghui Ryu, Eunkyu Lee, Song I Park, Minhae Park, Sang Duk Hong, Yong Gi Jung, Hyo Yeol Kim
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9489
_version_ 1797597427399655424
author Gwanghui Ryu
Eunkyu Lee
Song I Park
Minhae Park
Sang Duk Hong
Yong Gi Jung
Hyo Yeol Kim
author_facet Gwanghui Ryu
Eunkyu Lee
Song I Park
Minhae Park
Sang Duk Hong
Yong Gi Jung
Hyo Yeol Kim
author_sort Gwanghui Ryu
collection DOAJ
description Various chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mechanisms of the LDLT macrolide treatment have been reported, as well as their antimicrobial properties. Several mechanisms have already been identified in CRS, including reduced cytokines such as interleukin (IL)-8, IL-6, IL-1β, tumor necrosis factor-α, transforming growth factor-β, inhibition of neutrophil recruitment, decreased mucus secretion, and increased mucociliary transport. Although some evidence of effectiveness for CRS has been published, the efficacy of this therapy has been inconsistent across clinical studies. LDLT macrolides are generally believed to act on the non-type 2 inflammatory endotype of CRS. However, the effectiveness of LDLT macrolide treatment in CRS is still controversial. Here, we reviewed the immunological mechanisms related to CRS in LDLT macrolide therapy and the treatment effects according to the clinical situation of CRS.
first_indexed 2024-03-11T03:05:55Z
format Article
id doaj.art-afa26d46d7084cd7a40ddac9933fd51d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:05:55Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-afa26d46d7084cd7a40ddac9933fd51d2023-11-18T07:59:43ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411948910.3390/ijms24119489The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic RhinosinusitisGwanghui Ryu0Eunkyu Lee1Song I Park2Minhae Park3Sang Duk Hong4Yong Gi Jung5Hyo Yeol Kim6Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang 10380, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaVarious chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mechanisms of the LDLT macrolide treatment have been reported, as well as their antimicrobial properties. Several mechanisms have already been identified in CRS, including reduced cytokines such as interleukin (IL)-8, IL-6, IL-1β, tumor necrosis factor-α, transforming growth factor-β, inhibition of neutrophil recruitment, decreased mucus secretion, and increased mucociliary transport. Although some evidence of effectiveness for CRS has been published, the efficacy of this therapy has been inconsistent across clinical studies. LDLT macrolides are generally believed to act on the non-type 2 inflammatory endotype of CRS. However, the effectiveness of LDLT macrolide treatment in CRS is still controversial. Here, we reviewed the immunological mechanisms related to CRS in LDLT macrolide therapy and the treatment effects according to the clinical situation of CRS.https://www.mdpi.com/1422-0067/24/11/9489chronic rhinosinusitismacrolidecytokinesneutrophilsnasal polyps
spellingShingle Gwanghui Ryu
Eunkyu Lee
Song I Park
Minhae Park
Sang Duk Hong
Yong Gi Jung
Hyo Yeol Kim
The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
International Journal of Molecular Sciences
chronic rhinosinusitis
macrolide
cytokines
neutrophils
nasal polyps
title The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
title_full The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
title_fullStr The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
title_full_unstemmed The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
title_short The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
title_sort mechanism of action and clinical efficacy of low dose long term macrolide therapy in chronic rhinosinusitis
topic chronic rhinosinusitis
macrolide
cytokines
neutrophils
nasal polyps
url https://www.mdpi.com/1422-0067/24/11/9489
work_keys_str_mv AT gwanghuiryu themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT eunkyulee themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT songipark themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT minhaepark themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT sangdukhong themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT yonggijung themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT hyoyeolkim themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT gwanghuiryu mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT eunkyulee mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT songipark mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT minhaepark mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT sangdukhong mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT yonggijung mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis
AT hyoyeolkim mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis